Featured Research

from universities, journals, and other organizations

Gene Discovery Linked To Muscle Atrophy In Numerous Conditions

Date:
March 21, 2002
Source:
National Space Biomedical Research Institute
Summary:
A newly identified gene, atrogin-1, is involved in muscle loss associated with cancer, diabetes, fasting and kidney disease as well as in the atrophy occurring with disuse, inactivity, and nerve or spinal injury.

HOUSTON-(March 20, 2002) -- A newly identified gene, atrogin-1, is involved in muscle loss associated with cancer, diabetes, fasting and kidney disease as well as in the atrophy occurring with disuse, inactivity, and nerve or spinal injury.

This discovery, funded by the National Space Biomedical Research Institute (NSBRI) and the Muscular Dystrophy Association, increases the understanding of how muscles atrophy and may lead to development of new treatments for muscle wasting on Earth and in space.

"Through a study of rat muscles, we determined that atrogin-1 is found only in muscle," said Dr. Alfred Goldberg, professor of cell biology at Harvard Medical School and associate leader of NSBRI's team of scientists focusing on muscle loss in space. "In normal muscles, the amount is low; however, there is a dramatic increase in the production of the atrogin-1 protein in conditions where muscles lose size and strength."

In healthy muscles, there is a continual process of muscle protein production and breakdown. With muscle-wasting conditions, this cycle gets out of balance. Protein breakdown occurs more rapidly than protein production, leading to loss of muscle weight.

"Proteins in cells are destroyed in a structure called the proteasome," Goldberg said. "From clues in its gene sequence, we guessed that atrogin-1 was a component of this pathway of protein breakdown and succeeded in proving atrogin-1 targets other proteins for destruction."

Goldberg and associates, Dr. Marcelo Gomes, Dr. Stewart Lecker and Dr. Thomas Jagoe, set out to look for genes activated only during muscle atrophy. Using gene microarray analysis, the group studied muscle samples from healthy rats and those experiencing various muscle-wasting conditions.

"Genes code for the various proteins in our cells, and the information in our genes is expressed through the use of molecular messengers, called messenger RNAs," Goldberg said. His group searched atrophying muscles for new types of messenger RNAs since these molecules convey the news of what genes are being expressed.

"We found a fragment of a messenger RNA that increased dramatically in muscle atrophy," he said. "Cloning techniques allowed us to discover the atrogin-1 gene's full sequence and to produce the protein that it codes for. We then determined that it played a role in atrophy, where it seems to trigger the excessive protein breakdown."

Goldberg's group chose the name, atrogin-1, as short for atrophy-related gene. Their findings appear in the Dec. 4 issue of the Proceedings of the National Academy of Science.

In earlier studies, the group was the first to establish that muscle atrophy is due primarily to excessive protein breakdown and the first to indicate that a similar biochemical process was responsible for muscle loss in many different diseases.

Goldberg feels the atrophy process is similar in humans.

"Almost everything we know about human muscle function was first discovered in experimental animals," he said. "The atrogin-1 gene in humans is almost identical to that in mice and rats."

Many could potentially benefit from drugs designed to block or slow down muscle atrophy, from cancer patients to the bedridden to those losing muscle while in a cast. Even astronauts on long missions, who lose muscle while in space, will need a means to control muscle loss.

"If you could inhibit atrogin-1 or block a cell's ability to make it, you could reduce muscle wasting," Goldberg said. "Atrogin-1 is an attractive target for drug therapy since it is only found in muscle and plays a critical role in the atrophy process."

Goldberg's lab is now analyzing muscle biopsies of people with muscle-wasting diseases to determine if atrogin-1 is involved in human disease.

The NSBRI, funded by NASA, is a consortium of institutions studying the health risks related to long-duration space flight. Members include Baylor College of Medicine, Brookhaven National Laboratory, Harvard, The Johns Hopkins University, Massachusetts Institute of Technology, Morehouse School of Medicine, Mount Sinai School of Medicine, Rice University, Texas A&M University, University of Arkansas for Medical Sciences, University of Pennsylvania Health System and University of Washington.


Story Source:

The above story is based on materials provided by National Space Biomedical Research Institute. Note: Materials may be edited for content and length.


Cite This Page:

National Space Biomedical Research Institute. "Gene Discovery Linked To Muscle Atrophy In Numerous Conditions." ScienceDaily. ScienceDaily, 21 March 2002. <www.sciencedaily.com/releases/2002/03/020321070908.htm>.
National Space Biomedical Research Institute. (2002, March 21). Gene Discovery Linked To Muscle Atrophy In Numerous Conditions. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2002/03/020321070908.htm
National Space Biomedical Research Institute. "Gene Discovery Linked To Muscle Atrophy In Numerous Conditions." ScienceDaily. www.sciencedaily.com/releases/2002/03/020321070908.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins